BenevolentAI to power small molecule drug discovery – Pharmaphorum

BenevolentAI has entered a two-year agreement with the Medical Research Council’s to investigate new small molecule and antibody drug candidates.

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!